MarketScreener Strategies Claritas Pharmaceuticals, Inc.

Equities

End-of-day quote Toronto S.E. Other stock markets 06:00:00 2022-07-18 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	-16.67%		-.--%	-.--%

2021	Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107	MT
2021	Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107	CI

No results for this search